Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel versus ticagrelor/prasugrel in elderly patients with acute coronary syndrome
NL-OMON47836Phase 4Active, not recruiting
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of clopidogrel, ticagrelor and prasugrel in acute coronary syndrome (ACS) and coronary arteriosclerosis (2 arms), sponsored by St. Antonius Ziekenhuis. Primary endpoints: Any bleeding episode at 1 year and Net clinical benefit at 1 year. Started Jul 2013; status: active, not recruiting.
02
Drugs
clopidogrelticagrelorprasugrel
03
Conditions
acute coronary syndrome (ACS)coronary arteriosclerosis
Beyond the preview
Go deeper on NL-OMON47836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47836.